6月19日

大家好—

本周的美国疾控中心《合理用盐电子报》(Salt e-Update)内容包括：纽约市要求一些含钠过高的餐厅食物贴上潜在健康风险警示标识；雀巢公司在减钠方面进行了尝试和努力。

纽约力图为高钠餐厅食物贴上健康风险警示标识

最近,纽约市卫生和精神卫生局(NYCDOH)提出一项修正案,要求连锁餐厅在菜单和餐牌上加上警示标识，标明哪些餐品的钠含量超过了每日推荐限额的总量(2300毫克)。据纽约市卫生和精神卫生局(NYCDOH)介绍，那些连锁食品服务机构在纽约销售的餐品中，约有10%的餐品由于至少含有2300毫克的钠而受此修正案的影响，所以会被要求贴上警示标识。

如您对“第八十一条：食品制作和服务机构”提出的修正案有任何书面意见建议，请于2015年7月29日下班前提交至邮箱resolutioncomments@health.nyc.gov，或登录NYC Rules进行提交。您也可以在2015年7月29日召开的公开听证会期间口头提供您的意见建议；参加听证会者需要与 Svetlana Burdeynik联系提前预约，联系电话：347-396-6078.

如需更多信息，请登录：/upload/xintan/filedr/302c0d55a7dc331434c9fbea17717593.pdf及http://www.nyc.gov/html/doh/html/diseases/salt.shtml.  

雀巢公司继续降低旗下各子品牌食品中的钠含量

雀巢美国公司(Nestlé USA)最近宣布，计划在2015年底之前将该公司最受欢迎的冷冻比萨和零食产品中的钠含量减少10%。基于销售量加权平均而制定的这次减钠目标将会影响到该公司在美国6各品牌（DiGiorno®, Tombstone®, California Pizza Kitchen®, Jack’s®, Hot Pockets® and Lean Pockets®）下的超过250种产品,以及这些品牌于今年春天推出的新产品。2013年,雀巢公司(Nestlé USA)就承诺进一步削减其汤类、面条、混合食材、冷冻和冷藏食物以及披萨等产品中的盐含量,涵盖了Maggi、Stouffer’s、DiGiorno和Buitoni等子品牌的众多产品。

如需更多信息，请点击链接：http://www.nestleusa.com/media/pressreleases/pizza-.

感谢您一直以来对减钠行动的积极参与。

我们发送这些信息，目的是向正为正在发生的各种减钠活动的相关人士提供资讯。我们希望通过这种交流，能够为相关人士提供减钠方面的最新进展情况，并建立起一个合作网络，共同致力于减钠行动。《合理用盐电子报》(Salt e-Update)每两周发送一期。如有问题或意见，以及订阅或退订此信息，请与Jessica Levings 联系，邮箱JLevings@cdc.gov.。

《合理用盐电子报》(Salt e-Update)的内容完全是基于新闻价值和读者可能感兴趣这两条标准挑选出来的。美国疾控中心(CDC)对其内容的真实准确性不承担任何责任。选择哪些或不选择哪些消息作为内容，不代表美国疾控中心(CDC)支持任何立场。《合理用盐电子报》(Salt e-Update)中收录的消息原文作者所表达的观点，或文中引用的别人观点，均仅代表作者本人，绝不代表美国疾控中心(CDC)的官方立场。文中提及的产品、商标、出版物、新闻来源及网站名等相关参考文献均仅出于提供信息之目的，并不意味着美国疾控中心对此类信息的认同。

June 19

Hello –

This week’s CDC Salt e-Update includes potential warning labels on high sodium restaurant foods and Nestlé sodium reductions.

NYC Seeks Warning Labels on High Sodium Restaurant Foods
Recently, the New York City Department of Health and Mental Hygiene (NYCDOH) proposed an amendment that would require chain restaurants to post a warning label on menus and menu boards indicating items with a sodium content higher than the total daily recommended limit (2,300 mg). According to the NYCDOH, approximately 10% of menu items sold in NYC chain food service establishments covered by the proposal have at least 2,300 mg of sodium and would require the warning label.

Written comments on the proposed amendment to “Article 81 - Food Preparation and Food Service Establishments” may be submitted to resolutioncomments@health.nyc.gov or at NYC Rules until close of business on July 29, 2015. Verbal comments may be provided during a public hearing on July 29^th, 2015; participants can pre-register by contacting Svetlana Burdeynik at 347-396-6078.

More information may be found here: /upload/xintan/filedr/302c0d55a7dc331434c9fbea17717593.pdf and http://www.nyc.gov/html/doh/html/diseases/salt.shtml.  

Nestlé Continues Sodium Reductions Across Portfolio
Nestlé USA recently announced plans to reduce sodium by 10% in the company’s most-popular frozen pizza and snack products by the end of 2015. The reductions, based on sales weighted averages, will affect more than 250 products across six brands in the United States, including DiGiorno®, Tombstone®, California Pizza Kitchen®, Jack’s®, Hot Pockets® and Lean Pockets®, and also new products within these lines to be launched this spring. In 2013, Nestlé pledged further reductions in salt in products such as soups, noodles, recipe mixes, frozen and chilled meals, and pizzas, affecting the Maggi, Stouffer’s, DiGiorno, and Buitoni brands, among others.

More information may be found here: http://www.nestleusa.com/media/pressreleases/pizza-.  

Thank you for your continued engagement in sodium reduction.

We are sending this information in an effort to inform our stakeholders of relevant sodium reduction efforts that are occurring. The purpose of this communication is to provide continued follow up with stakeholders and create a network of partners working on and interested in sodium reduction. The Salt e-Update will be sent every two weeks. For questions or comments, or to be added or removed from this communication, contact Jessica Levings atJLevings@cdc.gov.

Salt e-Update content is selected solely on the basis of newsworthiness and potential interest to readers. CDC assumes no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC. Opinions expressed by the original authors of items included in Salt e-Update, or persons quoted therein, are strictly their own and are in no way meant to represent the official position of CDC. References to products, trade names, publications, news sources, and Websites are provided solely for informational purposes and do not imply endorsement by the CDC.